A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer
Clinical trial NCT03560479 · UNKNOWN
Trial details
- NCT number
- NCT03560479
- Sponsor
- Hamlet Pharma AB
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2021-12-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.